As of 2025-07-07, the Net Margin of Taysha Gene Therapies Inc (TSHA) is -1071.6%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -1071.6% |
2023-12-31 | -722.1% |
2022-12-31 | -6640.4% |
2021-12-31 | - |
2020-12-31 | - |
2019-12-31 | - |
- | |
- | |
- | |
- |